Literature DB >> 7350960

Diminished responses of nigral dopaminergic neurons to haloperidol and morphine following lesions in the striatum.

Y Kondo, K Iwatsubo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7350960     DOI： 10.1016/0006-8993(80)91278-0

Source DB:  PubMed          Journal:  Brain Res        ISSN： 0006-8993            Impact factor:   3.252


× No keyword cloud information.
  7 in total

1.  Kynurenate blocks the acute effects of haloperidol on midbrain dopamine neurons recorded in vivo.

Authors:  C S Tung; J Grenhoff; T H Svensson
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  Effects of morphine on dopamine metabolism in rat striatum and limbic structures in relation to the activity of dopaminergic neurones.

Authors:  P Moleman; C F van Valkenburg; J A vd Krogt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

3.  Withdrawal from repeated morphine sensitizes mice to the striatal dopamine release enhancing effect of acute morphine.

Authors:  J Airio; M Attila; T Leikola-Pelho; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

4.  Neuronal responses to iontophoretically applied dopamine, glutamate, and GABA of identified dopaminergic cells in the rat substantia nigra after kainic acid-induced destruction of the striatum.

Authors:  E Scarnati; C Pacitti
Journal:  Exp Brain Res       Date:  1982       Impact factor: 1.972

5.  Influence of acute and chronic haloperidol treatment on dopamine metabolism in the rat caudate-putamen, prefrontal cortex and amygdala.

Authors:  E C Essig; I C Kilpatrick
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopaminergic system.

Authors:  J L Andersson; M Marcus; G G Nomikos; T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

7.  Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms.

Authors:  Olivia Frånberg; Monica M Marcus; Vladimir Ivanov; Björn Schilström; Mohammed Shahid; Torgny H Svensson
Journal:  Psychopharmacology (Berl)       Date:  2009-02-07       Impact factor: 4.530
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.